Bill Title
To prohibit pharmaceutical manufacturers from interfering with therapeutically equivalent or interchangeable substitution decisions by health care providers to limit competition from a generic drug or biosimilar biological product, and for other purposes.
Committees
House Judiciary Committee
Bill Summary
Summary not yet available.
Bill
H.R.7473
Sponsor
Committee
House Judiciary Committee